Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    VolitionRx

    MCap

    USD76m

    Last close

    USD0.81

    ▲ 0.14 (20.90%)

    Canyon Resources

    MCap

    AUD262m

    Last close

    AUD0.19

    ▲ 0.02 (12.12%)

    Immix Biopharma

    MCap

    USD51m

    Last close

    USD1.82

    ▲ 0.12 (7.06%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Formycon (DB: FYB)

Last close As at 21/11/2024

61.30

▲ −0.20 (−0.33%)

Market capitalisation

677m

Edison Investment Research is terminating coverage on Formycon. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

Formycon — H121 update: Future markets take shape

Healthcare | Update

Formycon — FY20 results – core progress on key projects

Healthcare | Update

Formycon — Two submissions and two Phase III trials in 2021

Healthcare | Update

Formycon — FY19 results – strong position, new projects
Visit Website

Sector

Healthcare

Share Price Performance

Financials

Edison Investment Research is terminating coverage on Formycon. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Initiation

Healthcare

Formycon — Surfing the next wave of biosimilars